|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Centre for Exercise Science and Medicine, Institute of Biomedical and Life Sciences (Dr. Grant, Ms. Henderson, and Mr. Christie), and the Department of Statistics (Dr. Zare and Mr. Aitchison), University of Glasgow; and the Department of Cardiology (Drs. McMurray and Dargie), Western Infirmary, Glasgow, UK.
Correspondence to: S. Grant, PhD, Institute of Biomedical and Life Sciences, University of Glasgow, 64 Oakfield Ave, Glasgow, G12 8LT, UK; e-mail: S.Grant{at}bio.gla.ac.uk
Objective: To assess which subjective scale, the visual analogue scale (VAS), the Borg CR10 (Borg) scale, or the Likert scale (LS), if any, is decidedly more reproducible and sensitive to change in the assessment of symptoms.
Design: Prospective clinical study.
Setting: Exercise laboratory.
Participants: Twenty-three physically active male subjects (mean ± SD age of 30 ± 4 years old) were recruited.
Intervention: Each subject attended
the exercise laboratory on four occasions at intervals of 1 week. Three
subjective scales were used: (1) the VAS (continuous scale); (2) the
Borg scale (12 fixed points); and (3) the Likert scale (LS; 5 fixed
points). Four identical submaximal tests were given (2 min at 60%
maximum oxygen uptake [
O2max] and 6
min at 70%
O2max). Two tests
were undertaken to assess the reproducibility of scores that were
obtained with each subjective scale. Two other tests were undertaken to
assess the sensitivity of each scale to a change in symptom perception:
a double-blind treatment with propranolol, 80 mg, (ie,
active therapy; to increase the sensation of breathlessness and general
fatigue during exercise) or matching placebo. The subjective
scale scores were measured at 1 min 30 s, 5 min 30 s, and 7
min 15 s of exercise. Reproducibility was defined as the
proportion of total variance (ie, between-subject plus
within-subject variance) explained by the between-subject variance
given as a percentage. Sensitivity was defined as the effect of the
active drug therapy over the variation within subjects.
Results: Overall, the VAS performed best in terms of reproducibility for breathlessness and general fatigue, with reproducibility coefficients as high as 78%. For sensitivity, the VAS was best for breathlessness (ratio, 2.7) and the Borg scale was most sensitive for general fatigue (ratio, 3.0). The relationships between the respective psychological and physiologic variables were reasonably stable throughout the testing procedure, with overall typical correlations of 0.73 to 0.82
Conclusion: This study suggests that subjective scales can reproducibly measure symptoms during steady-state exercise and can detect the effect of a drug intervention. The VAS and Borg scales appear to be the best subjective scales for this purpose.
Key Words: breathlessness exercise testing general fatigue reproducibility sensitivity subjective scales
This article has been cited by other articles:
![]() |
W M Ip, J Woo, S Y Yue, M Kwan, S M. Sum, T Kwok, and S S. Hui Evaluation of the effect of energy conservation techniques in the performance of activity of daily living tasks Clinical Rehabilitation, March 1, 2006; 20(3): 254 - 261. [Abstract] [PDF] |
||||
![]() |
E. E. Swartz, S. A. Norkus, T. Cappaert, and L. C. Decoster Football Equipment Design Affects Face Mask Removal Efficiency Am. J. Sports Med., August 1, 2005; 33(8): 1210 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Carter, D. B. Holiday, J. Stocks, and B. Tiep Peak Physiologic Responses to Arm and Leg Ergometry in Male and Female Patients With Airflow Obstruction Chest, August 1, 2003; 124(2): 511 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. D. Bier, J. Wilson, P. Studt, and M. Shakleton Auricular Acupuncture, Education, and Smoking Cessation: A Randomized, Sham-Controlled Trial Am J Public Health, October 1, 2002; 92(10): 1642 - 1647. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Bauldoff, L. A. Hoffman, T. G. Zullo, and F. C. Sciurba Exercise Maintenance Following Pulmonary Rehabilitation* : Effect of Distractive Stimuli Chest, September 1, 2002; 122(3): 948 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
M A Dentener, E C Creutzberg, A M W J Schols, A Mantovani, C van`t Veer, W A Buurman, and E F M Wouters Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations Thorax, September 1, 2001; 56(9): 721 - 726. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |